Cerus Corp

CERSNASDAQ · USD
2.66USD0.00 (+5.14%)
3510

Cerus Corp (CERS) Implied Volatility Current

CERS implied volatility is 131%. IV Rank is 38%, placing current premiums in the middle of their 52-week range.

Read more

Tracking CERS implied volatility helps you identify when options premiums on Cerus Corp are historically cheap or expensive, and where the best trades are hiding. Cerus Corp implied volatility reflects the market's expectation of future price movement: when CERS IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Cerus Corp's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For CERS, tracking metrics like CERS IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on CERS signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced.

It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. The company was incorporated in 1991 and is headquartered in Concord, California.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where CERS implied volatility sits today versus where it has been. Our scanner ranks Cerus Corp implied volatility against its historical range, surfaces extremes in CERS IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Cerus Corp IV is rich or cheap — measure it, then act on it.

Implied Volatility

IV Rank
37.70%IV Rank
Moderate

IV is below its typical range - premiums look reasonable for buyers.

Implied Volatility (30d)131.41%

IV Rank37.70%

Historical Volatility (30d)48.59%

IV - HV+82.82%

As of September 17, 2026

Trade options with IV on your side

Track CERS IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.

Start your 14-day free trial